Ideagen PLC Total Voting Rights (4627K)
02 Septiembre 2021 - 1:00AM
UK Regulatory
TIDMIDEA
RNS Number : 4627K
Ideagen PLC
02 September 2021
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Total Voting Rights
In line with the Financial Conduct Authority's Disclosure and
Transparency Rules, Ideagen PLC (AIM: IDEA), a leading supplier of
Information Management Software to highly regulated industries,
announces that as at today's date, the Company's total issued share
capital is 254,655,400 ordinary shares of 1p each ("Ordinary
Shares") and the total number of voting rights will therefore be
254,655,400.
There are no shares held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the share capital of the Company under the FCA's Disclosure and
Transparency Rules.
Enquiries:
Ideagen plc 01629 699 100
Ben Dorks, Chief Executive Officer
Emma Hayes, Chief Financial Officer
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
FTI Consulting 020 3727 1000
Jamie Ricketts ideagen@fticonsulting.com
Dwight Burden
Valerija Cymbal
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
A global supplier of regulatory and compliance solutions,
Ideagen provides a common software platform and an integrated
risk-based approach to meet multi-industry standards, enabling
compliance with relevant laws, policies, and regulations.
The Group provides software and services to organisations
operating within highly regulated industries such as life sciences,
healthcare, banking and finance, insurance, aviation, and aerospace
and defence, with its main operational premises spread throughout
the UK, EU, US, Middle East and SE Asia.
Currently, over 6,000 organisations use Ideagen's products
including nine of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 250 hospitals across
the UK and US amongst its client base.
For further information please visit www.ideagen.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRLBMRTMTTMBMB
(END) Dow Jones Newswires
September 02, 2021 02:00 ET (06:00 GMT)
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024